Using Disease Models for Mechanistic Studies: Special Focus on Gene Editing

References

1. Geurts M.H. Gandhi S. Boretto M.G. Akkerman N. Derks L.L.M. van Son G. Celotti M. Harshuk-Shabso S. Peci F. Begthel H. Hendriks D. Schürmann P. Andersson-Rolf A. Chuva de Sousa Lopes S.M. van Es J.H. van Boxtel R. Clevers H. One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids. Nat. Commun. 2023 14 1 4998 10.1038/s41467‑023‑40701‑3 37591832
   [Google Scholar]
2. Davis J.R. Banskota S. Levy J.M. Newby G.A. Wang X. Anzalone A.V. Nelson A.T. Chen P.J. Hennes A.D. An M. Roh H. Randolph P.B. Musunuru K. Liu D.R. Efficient prime editing in mouse brain, liver and heart with dual AAVs. Nat. Biotechnol. 2024 42 2 253 264 10.1038/s41587‑023‑01758‑z 37142705
   [Google Scholar]
3. Liu N. Olson E.N. CRISPR modeling and correction of cardiovascular disease. Circ. Res. 2022 130 12 1827 1850 10.1161/CIRCRESAHA.122.320496 35679361
   [Google Scholar]
4. Li C. Fleck J.S. Martins-Costa C. Burkard T.R. Themann J. Stuempflen M. Peer A.M. Vertesy Á. Littleboy J.B. Esk C. Elling U. Kasprian G. Corsini N.S. Treutlein B. Knoblich J.A. Single-cell brain organoid screening identifies developmental defects in autism. Nature 2023 621 7978 373 380 10.1038/s41586‑023‑06473‑y 37704762
   [Google Scholar]
5. Wilkins H.M. Carl S.M. Swerdlow R.H. Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies. Redox Biol. 2014 2 619 631 10.1016/j.redox.2014.03.006 25460729
   [Google Scholar]
6. Furman D. Campisi J. Verdin E. Carrera-Bastos P. Targ S. Franceschi C. Ferrucci L. Gilroy D.W. Fasano A. Miller G.W. Miller A.H. Mantovani A. Weyand C.M. Barzilai N. Goronzy J.J. Rando T.A. Effros R.B. Lucia A. Kleinstreuer N. Slavich G.M. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 2019 25 12 1822 1832 10.1038/s41591‑019‑0675‑0 31806905
   [Google Scholar]
7. Li X. Li C. Zhang W. Wang Y. Qian P. Huang H. Inflammation and aging: Signaling pathways and intervention therapies. Signal Transduct. Target. Ther. 2023 8 1 239 10.1038/s41392‑023‑01502‑8 37291105
   [Google Scholar]
8. Schett G. Neurath M.F. Resolution of chronic inflammatory disease: Universal and tissue-specific concepts. Nat. Commun. 2018 9 1 3261 10.1038/s41467‑018‑05800‑6 30111884
   [Google Scholar]
9. Chavakis T. Alexaki V.I. Ferrante A.W. Macrophage function in adipose tissue homeostasis and metabolic inflammation. Nat. Immunol. 2023 24 5 757 766 10.1038/s41590‑023‑01479‑0 37012544
   [Google Scholar]
10. Zong Y. Li H. Liao P. Chen L. Pan Y. Zheng Y. Zhang C. Liu D. Zheng M. Gao J. Mitochondrial dysfunction: Mechanisms and advances in therapy. Signal Transduct. Target. Ther. 2024 9 1 124 10.1038/s41392‑024‑01839‑8 38744846
    [Google Scholar]
11. Wen H. Deng H. Li B. Chen J. Zhu J. Zhang X. Yoshida S. Zhou Y. Mitochondrial diseases: From molecular mechanisms to therapeutic advances. Signal Transduct. Target. Ther. 2025 10 1 9 10.1038/s41392‑024‑02044‑3 39788934
    [Google Scholar]
12. Xu W. Zhang S. Qin H. Yao K. From bench to bedside: Cutting-edge applications of base editing and prime editing in precision medicine. J. Transl. Med. 2024 22 1 1133 10.1186/s12967‑024‑05957‑3 39707395
    [Google Scholar]
13. Mathis N. Allam A. Kissling L. Marquart K.F. Schmidheini L. Solari C. Balázs Z. Krauthammer M. Schwank G. Predicting prime editing efficiency and product purity by deep learning. Nat. Biotechnol. 2023 41 8 1151 1159 10.1038/s41587‑022‑01613‑7 36646933
    [Google Scholar]
14. Sibbits J. Di Pietro L. Privitera A. Cardaci V. Maugeri S. Camarda M. Caruso G. 3D bioprinting and microfluidic-based devices for cancer detection and drug treatment: Focus on prostate cancer. Curr. Med. Chem. 2026 ••• 33 10.2174/0109298673298382240307040239 38468515
    [Google Scholar]
15. Kashirskikh D. Chicherina N. Glanz V. Orekhov A. Sobenin I. Mouse model of low-density lipoprotein desialylation in vivo. Curr. Med. Chem. 2026 ••• 33 10.2174/0109298673294745240528092506 38831578
    [Google Scholar]
16. Orekhov A.N. Sinyov V.V. Vyssokikh M.Y. Manukhova L. Marey M.V. Angelova P.R. Omelchenko A.V. Vinokurov A.Y. Khasanova Z.B. Sobenin I.A. Relationship between cellular oxygen consumption and atherosclerosis-associated mitochondrial mutations. Curr. Med. Chem. 2026 ••• 33 10.2174/0109298673302002240605092523 38879762
    [Google Scholar]
17. Nawaz Shah S. Younis W. Gasparotto A. Junior Manzoor W. Malik M.N.H. Mushtaq M.N. Munir M.U. Bashir A. Bibi S. Talha M. Livero F.A.R. Diuretic and anti-hyperuricemic effects of geranyl acetate in rats. Curr. Med. Chem. 2026 ••• 33 10.2174/0109298673300632240823061848 39234901
    [Google Scholar]
18. Khotina V.A. Vinokurov A.Y. Sinyov V.V. Zhuravlev A.D. Popov D.Y. Sukhorukov V.N. Sobenin I.A. Orekhov A.N. Mitochondrial dysfunction associated with mtDNA mutation: Mitochondrial genome editing in atherosclerosis research. Curr. Med. Chem. 2026 ••• 33 10.2174/0109298673323639240926095549 39400015
    [Google Scholar]
19. Borisov E.E. Summerhill V.I. Khotina V.A. Kosyreva A.M. Kovyanova T.I. Sukhorukov V.N. Orekhov A.N. Cells with defective mitophagy do not accumulate atherogenic LDL-derived cholesterol. Curr. Med. Chem. 2026 ••• 33 10.2174/0109298673294632250108102414 40017249
    [Google Scholar]
20. Wargantiwar S. Bhattacharya S. Kanugo A. Surgical advancements, immunotherapy, targeted and conventional therapies, biopsy, colposcopy, and Pap smear integration in the management of cervical cancer. Curr. Med. Chem. 2025 32 38 8556 8579 10.2174/0109298673337745241123054840 39844405
    [Google Scholar]
21. Aliakbarian M. Ashrafzadeh K. Ferns G.A. Hadian R. Khodashahi R. Arjmand M.H. NADPH oxidase: A potential therapeutic target to reduce primary sclerosis cholangitis following liver transplantation. Curr. Med. Chem. 2025 32 38 8598 8608 10.2174/0109298673356252250213105931 40012385
    [Google Scholar]
22. Kuźbicki L. The markers auxiliary in distinguishing between nodal nevi and melanoma metastases. Curr. Med. Chem. 2025 32 38 8580 8597 10.2174/0109298673358592250408170859 40511655
    [Google Scholar]
23. Bjørklund G. Gurgas L. Hangan T. Advanced glycation end products and skin autoimmune disorders: Pathogenic insights into vitiligo, bullous pemphigoid, and type 1 diabetes mellitus. Curr. Med. Chem. 2025 32 38 8495 8502 10.2174/0109298673374335250410074811 40289982
    [Google Scholar]
24. Zheng J. Shu D. Xu R. Zheng Y. Lin P. Lin Y. Zhao X. Cui L. Liao X. Guo B. Development and validation of a cholesterol-related gene signature for prognostic assessment in head and neck squamous cell carcinoma. Curr. Med. Chem. 2024 10.2174/0109298673336147241010065340 39411955
    [Google Scholar]
25. Li N. Yu K. Huang D. Guo H. Zhu X. Lin Z. Elucidating the role of autophagy-related genes in polycystic ovary syndrome: Implications for diagnostic models and immune response regulation. Curr. Med. Chem. 2024 10.2174/0109298673337033241010072529 39421991
    [Google Scholar]
26. Wang H. Peng C. Hu G. Chen W. Hu Y. Pi H. Integrated single-cell RNA-seq and bulk RNA-seq identify diagnostic biomarkers for postmenopausal osteoporosis. Curr. Med. Chem. 2024 10.2174/0109298673343344240930054414 39364870
    [Google Scholar]
27. Xu J. Li X. Zeng X. Bao H. Liu X. The punicalagin compound mitigates bronchial epithelial cell senescence induced by cigarette smoke extract through the PAR2/mTOR pathway. Curr. Med. Chem. 2024 10.2174/0109298673346794241001110826 39364871
    [Google Scholar]
28. Li D. Lyu G. Cartilage oligomeric matrix protein: A potential prognostic biomarker and therapeutic target in gastric cancer. Curr. Med. Chem. 2025 32 38 8647 8663 10.2174/0109298673360512250329171036 40277122
    [Google Scholar]
29. Mishra S.K. Chandra A. Mitra N. Krishna N. Singh N. Akash S. Jardan Y.A.B. Bourhia M. Georrge J.J. Exploring the dynamics of Asparagus racemosus phytochemicals as dual target inhibitors of monkeypox virus. Curr. Med. Chem. 2025 32 38 8678 8700 10.2174/0109298673361923250101072831 39931982
    [Google Scholar]
30. Orekhov A.N. Elizova N.V. Maksaeva A.O. Omelchenko A.V. Borodko D.D. Zhuravlev A.D. Vinokurov A.Y. Sinyov V.V. Sobenin I.A. Sukhorukov V.N. Mechanisms of inflammation chronification: Genetic and epigenetic regulation of intolerant response (Trained Immunity). Curr. Med. Chem. 2025 10.2174/0109298673431092250819054506 40910286
    [Google Scholar]
31. Frangoul H. Altshuler D. Cappellini M.D. Chen Y.S. Domm J. Eustace B.K. Foell J. de la Fuente J. Grupp S. Handgretinger R. Ho T.W. Kattamis A. Kernytsky A. Lekstrom-Himes J. Li A.M. Locatelli F. Mapara M.Y. de Montalembert M. Rondelli D. Sharma A. Sheth S. Soni S. Steinberg M.H. Wall D. Yen A. Corbacioglu S. CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. N. Engl. J. Med. 2021 384 3 252 260 10.1056/NEJMoa2031054 33283989
    [Google Scholar]
32. Musunuru K. Grandinette S.A. Wang X. Hudson T.R. Briseno K. Berry A.M. Hacker J.L. Hsu A. Silverstein R.A. Hille L.T. Ogul A.N. Robinson-Garvin N.A. Small J.C. McCague S. Burke S.M. Wright C.M. Bick S. Indurthi V. Sharma S. Jepperson M. Vakulskas C.A. Collingwood M. Keogh K. Jacobi A. Sturgeon M. Brommel C. Schmaljohn E. Kurgan G. Osborne T. Zhang H. Kinney K. Rettig G. Barbosa C.J. Semple S.C. Tam Y.K. Lutz C. George L.A. Kleinstiver B.P. Liu D.R. Ng K. Kassim S.H. Giannikopoulos P. Alameh M.G. Urnov F.D. Ahrens-Nicklas R.C. Patient-specific in vivo gene editing to treat a rare genetic disease. N. Engl. J. Med. 2025 392 22 2235 2243 10.1056/NEJMoa2504747 40373211
    [Google Scholar]
33. Zhang Q. Cao X. Epigenetic regulation of the innate immune response to infection. Nat. Rev. Immunol. 2019 19 7 417 432 10.1038/s41577‑019‑0151‑6 30918351
    [Google Scholar]
34. Wu D. Shi Y. Zhang H. Miao C. Epigenetic mechanisms of immune remodeling in sepsis: Targeting histone modification. Cell Death Dis. 2023 14 2 112 10.1038/s41419‑023‑05656‑9 36774341
    [Google Scholar]
35. Berni Canani R. Di Costanzo M. Leone L. The epigenetic effects of butyrate: Potential therapeutic implications for clinical practice. Clin. Epigenetics 2012 4 1 4 10.1186/1868‑7083‑4‑4 22414433
    [Google Scholar]
36. Fellows R. Denizot J. Stellato C. Cuomo A. Jain P. Stoyanova E. Balázsi S. Hajnády Z. Liebert A. Kazakevych J. Blackburn H. Corrêa R.O. Fachi J.L. Sato F.T. Ribeiro W.R. Ferreira C.M. Perée H. Spagnuolo M. Mattiuz R. Matolcsi C. Guedes J. Clark J. Veldhoen M. Bonaldi T. Vinolo M.A.R. Varga-Weisz P. Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases. Nat. Commun. 2018 9 1 105 10.1038/s41467‑017‑02651‑5 29317660
    [Google Scholar]
37. Hasin Y. Seldin M. Lusis A. Multi-omics approaches to disease. Genome Biol. 2017 18 1 83 10.1186/s13059‑017‑1215‑1 28476144
    [Google Scholar]
38. Hu T. Liu C.H. Lei M. Zeng Q. Li L. Tang H. Zhang N. Metabolic regulation of the immune system in health and diseases: Mechanisms and interventions. Signal Transduct. Target. Ther. 2024 9 1 268 10.1038/s41392‑024‑01954‑6 39379377
    [Google Scholar]